Tumor burden measured by bioluminescence was significantly reduced by annexin A2 neutralizing antibody treatment compared with mouse IgG antibody treatment over a 36 day period (Fig. 5C, Supplementary Fig. 3 and P < 0.05, Mann-Whitney U test). Here, ANXA2 is linked to neoplasm.